focus -WSS

focus

author：leisure time 2025-09-30 18:42:56 - browse：5553

House Judiciary Chairman Jerrold Nadler (D-NY) listens as Rep. Judy Chu (D-CA) speaks during a news conference. — Reps. Jerry Nadler (D-N.Y.) and Judy Chu (D-Calif.) Joshua Roberts/Getty Images

House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better oversight, citing recent STAT investigations that found insurance companies are using artificial intelligence and algorithmic software to deny care even when people still need it.

On Friday, Rep. Judy Chu of California and Rep. Jerry Nadler of New York spearheaded a letter to the Centers for Medicare and Medicaid Services asking the agency to step up its oversight of Medicare Advantage insurers. Thirty other House Democrats also signed onto the letter.

STAT previously reported Medicare Advantage insurers are using proprietary algorithms and AI to initiate payment denials, but that technology does not fully account for someone’s particular care needs. As a result, many frail patients have been kicked out of nursing homes, faced the prospect of draining their savings, or slogged through a long appeals process to get care they and their clinical teams think they need.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

WSS

Alabama IVF ruling threatens families facing fatal genetic disease

STAT readers on older presidents, polypills, Medicare, and more

A solution to the after

Alabama IVF ruling threatens families facing fatal genetic disease

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

Alabama frozen embryo ruling has major implications for IVF clinics

Wikipedia

focus

focus

Apple is now the first public company to be valued at $3 trillion

Readout Newsletter: Bristol, Sangamo, Gilead, and more

Hepatitis C has a cure — but many Americans still lack access to it

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Ebola: Gilead Sciences antiviral shows promise as new treatment

ChatGPT in medicine: STAT answers readers' burning questions

Male and female sex labels in research insufficient, scientists say

Jerome Adams on the need for new antivirals for Covid

Pushing for an NIH office for post

knowledge

A solution to the after

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

With competition flaring, obesity drug hits goal in liver disease study

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

As AI in medicine takes off, can 'human in the loop' prevent harm?

Boston's new lab space is opening empty

Wikipedia

entertainment

hotspot

Wikipedia